Speaking to BioSpace in San Francisco, Elena Koundourakis, the head of the orexin franchise at Takeda Pharmaceuticals, gave a preview of what is ahead for its aims to treat narcolepsy.
Q&A: Takeda’s Elena Koundourakis Talks Orexin Program Ahead of Expected Readout Read More »
Dropping the potential Cytokinetics buy runs contrary to Novartis’ recent dealmaking frenzy, which included the acquisition of Calypso and three research collaborations.
Amgen Emerges as Potential Cytokinetics Suitor as Novartis Pulls Away: Reports Read More »
The agency nevertheless said that it could not definitively rule out a small risk of suicidal ideation associated with GLP-1 receptor agonists, and that it will continue evaluating the evidence.
FDA Finds no Link Between GLP-1 Drugs and Suicidal Thoughts Read More »
In part two of a three-part series, Alex Momeni, partner at General Catalyst, discusses digital health consolidation and when the IPO market could unfreeze.
Biogen gained exclusive ex-U.S. rights to Ampyra in 2009 and is selling the drug under the brand name Fampyra in international markets.
Amid Declining Sales, Biogen Hands MS Drug Fampyra Back to Acorda Read More »
Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities General Regulation, Innate Pharma SA releases its total number of shares outstanding as well as its voting rights as at January 1, 2024.
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024 Read More »
Las explosiones supernova se destacan como los eventos más espectaculares y cataclísmicos. Sin embargo, la pregunta que intriga a muchos es: ¿Cuándo podrían estas asombrosas explosiones convertirse en amenazas reales para nuestro planeta? Las Maravillas de …
La Vía Láctea, esa imponente franja de luz que adorna nuestro cielo nocturno, es el hogar de innumerables estrellas, planetas y sistemas solares. En este vasto rincón del cosmos, la Tierra ocupa un lugar especial, pero ¿en qué brazo galáctico reside nuestro …
¿En qué brazo galáctico se halla la Tierra en la Vía Láctea? Read More »
BioInvent International AB announced that its early discovery partner Exelixis, Inc. has provided a notice of termination for the option and license agreement for novel antibodies for use in immuno-oncology therapeutics.
BioInvent Regains Rights to Immuno-Oncology Targets from Exelixis Read More »
El colapso gravitacional se refiere al proceso por el cual una región de materia experimenta una contracción bajo la influencia de su propia gravedad. Este fenómeno es fundamental en la formación de estructuras a gran escala en el universo, como estrellas, galaxias y c&ua …
